CN115558555A - Novel lavender fragrance source and preparation method thereof - Google Patents

Abstract

The invention discloses a novel lavender fragrance source and a preparation method thereof, and relates to the technical field of fragrance source processing. The invention comprises the following raw materials in parts by weight: 50-70 parts of lavender material, 0-10 parts of lavender essential oil, 0.1-10 parts of lavender flower wax, 0.1-5 parts of lavender absolute, 0-5 parts of fragrance slow-release agent, 3-10 parts of valerian essential oil, 0.04-0.08 part of limonene, 0.06-0.07 part of beta-pinene, 0.04-0.09 part of gamma-terpinene, 0.01-0.015 part of linalool, 0.01-0.06 part of geraniol, 0.03-0.07 part of nerol, 0.03-0.08 part of terpineol, 0.005-0.01 part of leaf alcohol, 0.06-0.09 part of eugenol, 0.04-0.08 part of valeric acid, 0.05-0.08 part of benzoic acid, 0.007-0.012 part of salicylic acid, 0.01-0.03 part of geranyl acetate, 0.02-0.05 part of methyl salicylate, 0.1-5.01-0.08 part of lavender wax, 0.15-0.15 parts of pure water extract and 0.15-10 parts of pure water extract. Through the improvement of the formula, the fragrance source body can have longer fragrance-retaining time when in use, and can provide the functions of improving sleep and regulating mood for users.

Description

Novel lavender fragrance source and preparation method thereof

Technical Field

The invention belongs to the technical field of processing of fragrance sources, and particularly relates to a novel lavender fragrance source and a preparation method thereof.

Background

Flowers, leaves and stems of natural lavender are natural aromatic plants with aromatic substances, the lavender distilled essential oil is volatile oil, the lavender flower wax and the lavender flower oil extracted by carbon dioxide are substances of small molecular volatile oil wrapped by large-chain oil molecules, and the lavender aroma slow-release agent (aroma slow-release microcapsule and aroma slow-release nanocapsule) can be called as natural perfume which is concentrated and has the slow-release aroma effect.

The volatile substances in the lavender are rich in linaloe lipid and linalool, and have the main effects of soothing the nerves, helping sleep, soothing anxiety and the like. The lavender plant contains aromatic alcohol, flavone, camphor and polysaccharide, and has antibacterial and bacteriostatic effects on purifying air.

The head fragrance of the traditional fragrance source body such as lavender essential oil can be quickly volatilized within 1 hour at normal temperature, and no middle fragrance and tail fragrance exist; the natural fragrance source such as lavender flower buds has weak head fragrance, and the natural fragrance source such as lavender flower buds can generally last for 30-60 days at normal temperature after being crushed and ashed if the natural fragrance source and the tail fragrance need to be generated; the traditional perfume source body has short perfume-retaining time, is used as a filler, is easy to breed bacteria or mites, has low sanitary and safety performance, and has poor stability, such as lavender buds, is difficult to place for a long time and is easy to ash and lose efficacy.

Disclosure of Invention

The invention aims to provide a novel lavender fragrance source and a preparation method thereof, and aims to solve the problems in the background art.

In order to solve the technical problems, the invention is realized by the following technical scheme:

the invention relates to a novel lavender fragrance source, which comprises the following raw materials in parts by weight: 50-70 parts of lavender material, 0-10 parts of lavender essential oil, 0.1-10 parts of lavender flower wax, 0.1-5 parts of lavender absolute, 0-5 parts of fragrance slow-release agent, 3-10 parts of valerian essential oil, 0.04-0.08 part of limonene, 0.06-0.07 part of beta-pinene, 0.04-0.09 part of gamma-terpinene, 0.01-0.015 part of linalool, 0.01-0.06 part of geraniol, 0.03-0.07 part of nerol, 0.03-0.08 part of terpineol, 0.005-0.01 part of leaf alcohol, 0.06-0.09 part of eugenol, 0.04-0.08 part of valeric acid, 0.05-0.08 part of benzoic acid, 0.007-0.012 part of salicylic acid, 0.01-0.03 part of geranyl acetate, 0.02-0.05 part of methyl salicylate, 0.1-5.01-0.08 part of lavender wax, 0.15-0.15 parts of pure water extract and 0.15-10 parts of pure water extract.

Further, the feed additive comprises the following raw materials in parts by weight: 70 parts of lavender material, 0.1 part of lavender flower wax, 0.1 part of lavender absolute, 3 parts of valerian essential oil, 0.04 part of limonene, 0.06 part of beta-pinene, 0.04 part of gamma-terpinene, 0.01 part of linalool, 0.01 part of geraniol, 0.03 part of nerol, 0.03 part of terpineol, 0.005 part of leaf alcohol, 0.06 part of eugenol, 0.04 part of valeric acid, 0.05 part of benzoic acid, 0.007 part of salicylic acid, 0.01 part of geranyl acetate, 0.02 part of methyl salicylate, 0.1 part of lavender extract, 1 part of adhesive, 0.01 part of bactericide and 40 parts of purified water.

Further, the feed additive comprises the following raw materials in parts by weight: 60 parts of lavender material, 5 parts of lavender essential oil, 5 parts of lavender flower wax, 3 parts of lavender absolute oil, 2.5 parts of fragrance slow-release agent, 7 parts of valerian essential oil, 0.05 part of limonene, 0.065 part of beta-pinene, 0.06 part of gamma-terpinene, 0.012 part of linalool, 40.0 parts of geraniol, 0.05 part of nerol, 0.05 part of terpineol, 0.0075 part of leaf alcohol, 0.08 part of eugenol, 0.06 part of valeric acid, 0.07 part of benzoic acid, 0.009 part of salicylic acid, 0.02 part of geranyl acetate, 0.03 part of methyl salicylate, 3 parts of lavender extract, 15 parts of adhesive, 0.08 part of bactericide and 80 parts of purified water.

Further, the feed additive comprises the following raw materials in parts by weight: 65 parts of lavender material, 7 parts of lavender essential oil, 8 parts of lavender flower wax, 4 parts of lavender absolute oil, 3 parts of fragrance slow-release agent, 8 parts of valerian essential oil, 0.065 part of limonene, 0.067 part of beta-pinene, 0.08 part of gamma-terpinene, 0.014 part of linalool, 0.05 part of geraniol, 0.06 part of nerol, 0.06 part of terpineol, 0.0085 part of leaf alcohol, 0.07 part of eugenol, 0.05 part of valeric acid, 0.068 part of benzoic acid, 0.011 part of salicylic acid, 0.025 part of geranyl acetate, 0.04 part of methyl salicylate, 2.5 parts of lavender extract, 8 parts of adhesive, 0.1 part of bactericide and 100 parts of purified water.

Further, the feed additive comprises the following raw materials in parts by weight: 50 parts of lavender material, 10 parts of lavender essential oil, 10 parts of lavender flower wax, 5 parts of lavender absolute, 5 parts of fragrance slow-release agent, 10 parts of valerian essential oil, 0.08 part of limonene, 0.07 part of beta-pinene, 0.09 part of gamma-terpinene, 0.015 part of linalool, 0.06 part of geraniol, 0.07 part of nerol, 0.08 part of terpineol, 0.01 part of leaf alcohol, 0.09 part of eugenol, 0.08 part of valeric acid, 0.08 part of benzoic acid, 0.012 part of salicylic acid, 0.03 part of geranyl acetate, 0.05 part of methyl salicylate, 5 parts of lavender extract, 25 parts of adhesive, 0.15 part of bactericide and 150 parts of purified water.

A preparation method of a novel lavender fragrance source is used for any one of the above steps:

s1, preparing raw materials: selecting a dry lavender material, and preparing lavender essential oil, lavender flower wax, lavender absolute oil, a fragrance slow-release agent, valerian essential oil, limonene, beta pinene, gamma terpinene, linalool, geraniol, nerol, terpineol, leaf alcohol, eugenol, valeric acid, benzoic acid, salicylic acid, geranyl acetate, methyl salicylate, lavender extract, an adhesive, a bactericide and purified water according to the weight part ratio;

s2, crushing raw materials: crushing the lavender material by adopting crushing equipment;

s3, mixing and stirring materials: adding the lavender crushed material and other prepared raw materials into a mixing device, and stirring and mixing to obtain a fragrance source mixed material;

s4, forming and manufacturing: adopting a forming device to mix the fragrance source body into a fragrance source body initial product;

s5, drying: drying the primary fragrance source product by a hot air circulation oven at 20-50 ℃ to obtain a fragrance source product, and recovering evaporated water generated in the drying process by a snake-shaped circulation condenser;

s6, packaging and warehousing: inspecting the fragrance source product, packaging with food-grade plastic bags after the inspection is qualified, quantitatively sealing each bag, and packaging into a warehouse.

Further, filtering the crushed raw materials in the step S2 by using a filtering device to obtain a lavender crushed material with a particle size of 30-120 meshes.

Further, between the step S5 and the step S6, polishing processing is performed on the fragrance source product by using a polishing device.

Furthermore, the adhesive is made of syrup or corn starch, and the bactericide is dichlorobenzyl alcohol.

Further, the crushing equipment adopts a YSF-25 type traditional Chinese medicine cell wall breaking crusher or a ZJ-BC100 type grading impact mill;

the mixing equipment adopts a WCH-100 type groove mixer;

the forming device adopts a WK-300 type semi-automatic traditional Chinese medicine pill making machine or an MM08/15/30/60 type pouring machine.

The invention has the following beneficial effects:

1. through the improvement of the formula, the fragrance source body can have longer fragrance-retaining time when in use, and can provide the functions of improving sleep and regulating mood for users.

2. According to the invention, the lavender fragrance source, the lavender essential oil, the lavender flower wax, the lavender absolute oil, the fragrance slow-release agent and the lavender extract have a good slow-release effect on the head fragrance of the lavender fragrance and the middle fragrance and the tail fragrance after slow release, so that the fragrance retention time of the fragrance source is prolonged, and the olfactory effect is obvious; the bactericide is adopted, so that the growth of fungi such as mites can be effectively prevented; the lavender extract and the adhesive are matched, so that the pressure resistance, the wear resistance, the elasticity and the shatter resistance of the formed fragrance source body can be enhanced, one or more mixed materials of lavender buds, lavender leaves and lavender stems are adopted, the utilization rate of natural objects is improved, the economic and social benefits are also remarkable, and the profitability of flower growers can be increased.

Detailed Description

The technical solutions in the embodiments of the present invention will be described clearly and completely below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

The first embodiment is as follows:

the invention relates to a novel lavender fragrance source, which comprises the following raw materials in parts by weight: 50-70 parts of lavender material, 0-10 parts of lavender essential oil, 0.1-10 parts of lavender flower wax, 0.1-5 parts of lavender absolute, 0-5 parts of fragrance slow-release agent, 3-10 parts of valerian essential oil, 0.04-0.08 part of limonene, 0.06-0.07 part of beta-pinene, 0.04-0.09 part of gamma-terpinene, 0.01-0.015 part of linalool, 0.01-0.06 part of geraniol, 0.03-0.07 part of nerol, 0.03-0.08 part of terpineol, 0.005-0.01 part of leaf alcohol, 0.06-0.09 part of eugenol, 0.04-0.08 part of valeric acid, 0.05-0.08 part of benzoic acid, 0.007-0.012 part of salicylic acid, 0.01-0.03 part of geranyl acetate, 0.02-0.05 part of methyl salicylate, 0.1-5.01-0.08 part of lavender wax, 0.15-0.15 parts of pure water extract and 0.15 parts of pure water extract;

in the embodiment, through the matching of limonene, beta-pinene and gamma-terpinene, the fragrance source body can have the functions of purifying air, influencing the concentration of serotonin and dopamine in the body, reducing depression and improving emotion;

in the embodiment, through the matching of geraniol, benzoic acid, methyl salicylate and salicylic acid, the fragrance source body can have the effects of euphoria and sedation on the nervous system, is beneficial to relieving the feelings of anxiety, tension, shock, panic and fear, and is very effective in relieving tachypnea and tachycardia;

in the embodiment, by matching linalool, nerol, terpineol, leaf alcohol, eugenol, valeric acid and geranyl acetate, the nerve calming effect can be achieved, the insomnia treatment benefit can be achieved, and neuralgia, headache and dizziness can be improved;

the bactericide in the embodiment is a mite bacteriostatic agent.

Preferably, the lavender essential oil is extracted by a distillation method, the lavender flower wax is extracted by a carbon dioxide method, the lavender absolute oil is extracted by a carbon dioxide method, and the lavender extract is extracted by ultrasonic waves;

1) Antibacterial effect of lavender

Lavender has inhibitory effect on Staphylococcus aureus, streptococcus and Sarcina, and aromatic alcohol therein has antibacterial and antifungal effects; lis-Balchin (1998) found that aromatic alcohol is the main antibacterial component of lavender essential oil, and can inhibit the growth of 17 bacteria (G + and G-) and 10 fungi, and in vitro experiments show that lavender essential oil with the concentration of less than 1% has the effects of resisting methicillin-resistant staphylococcus aureus (MRSA) and enterococcus faecalis. The research reports that the lavender essential oil vapor can also inhibit the growth of aspergillus fumigatus mycelia, the effective concentration of the lavender essential oil vapor on trichophyton mentagrophytes and trichophyton rubrum is 10-20 mu g/ml, and 60 spores can be killed when the concentration is 150 mu g/ml. Inouye et al (2001) showed that lavender essential oil could not treat deep infections but only local infections, as demonstrated by in vitro antimicrobial activity tests. Shen Lina can be used for treating 4 tinea pedis patients with conventional drug-induced ineffectiveness by using preparation containing lavender essential oil and herba Equiseti hiemalis extract. He Ruizhen can be used for treating tinea manus and tinea pedis with self-made XIANGCHUN tincture (containing Lavender essential oil and radix Stemonae).

2) Sedative hypnotic and anticonvulsive effects of lavender

The use of lavender essential oil for aromatherapy is of great benefit, and Diego et al 1998 found that inhalation of 10% lavender essential oil by a subject for 3min showed significant physical relaxation, a reduction in anxiety score, a good mental state and an increase in sleep. It has been reported that after the administration of hypnotics such as temazepam, chlorpromazine, and chlormethiazole is stopped for 31 mental patients for 2 weeks, the odor of lavender essential oil is put into a ward, and the sleep time of the patients is the same as that of the hypnotics every night. Liu Shu liters and the like are used for treating 50 patients with neurosis by smelling fragrance with lavender flowers, and one treatment course is 8 weeks, so that sleep disorder, mood disorder, somatization symptoms, electroencephalogram and cerebral hemogram of the neurosis are improved, and no adverse reaction is seen. French lavender has been reported to be used for folk therapy of many central nervous system diseases, and has anticonvulsant effect by inhaling lavender oil vapor. In addition, through animal experiments, the authors inject 600mg/kg of lavender flower extract into the abdominal cavity to have no hypnotic effect on the sleep of the mice induced by pentobarbital, but can prolong the sleep time from 39.4min to 65.4min, the effect is similar to that of diazepam, and the lavender flower extract has a sedative effect. In addition, lavender oil is reported to relieve mania of patients with severe dementia, 18% -65% of patients with senile dementia have mania, and the first-line medicament for treating the mania is a tranquilizer, but has large side effect. The authors carried out clinical trials, evaluating from 4 aspects, on the premise that inhalation of lavender oil could have a beneficial effect on manic behavior in patients with severe dementia: the abnormal voice is used for speaking, the action is maniac, the invasive behavior and the counter-resistance nursing are carried out, and the evaluation result of the patients shows that 60 percent of the patients have improvement. The experts consider that the lavender oil has moderate curative effect on the manic behavior of the patients with the severe dementia.

3) Lavender spasmolytic and analgesic effects

The function of lavender is negotiated in a book of 'New drug materia Medica' in China: the oil has effect in promoting qi circulation, and can be used for treating flatulence and colic by dripping oil or its alcohol solution on sugar. The compound Lavender tincture has effects of promoting qi circulation and resisting spasm. Lis-Balchin M, hart S demonstrated the spasmolytic effect of lavender in vitro experiments in guinea pig ileum and rat uterus, and the spasmolytic effect of lavender oil was not through adrenergic and cholinergic receptors, probably by increasing intracellular adenosine monophosphate levels. In animal experiments, the lavender dried flower extract with the concentration of 0.1-1.0 mg/ml is added into in-vitro rabbit jejunum culture solution in animal experiments, so that spontaneous contraction of intestinal canals can be inhibited, and spasmolysis is shown, and the effect is similar to verapamil. After the jejunum is washed for 2 times, the spasmolysis can be reversed, spontaneous contraction is recovered, and the spasmolytic activity of the jejunum can be related to the contained 7-methoxycoumarin (having muscle relaxation effect).

The data in the Duke phytochemistry and ethnic phytochemistry databases show that lavender oil contains cholinesterase inhibitors 1,8-eucalyptol, borneol, coumarin and limonene, which have analgesic, anesthetic, anti-nociceptive (i.e., alleviating the sensation of pain), muscle relaxant and calming effects. Style et al (1997) reported that topical application of vegetable oils such as lavender can relieve pain in children with HIV. Woolfson et al (1992) reported that topical application of lavender oil in an emergency situation reduced the sensation of pain. In 1998, a cross-over study by Brownfield showed that massage with lavender essential oil reduced the pain sensation of the patient, improved sleep quality and reduced pain in patients with chronic rheumatoid arthritis. The lavender essential oil can also relieve pain and discomfort of parturient after delivery.

4) Fast allergic response inhibiting effect of lavender Kim HM, cho SH studied the effect of lavender oil in mast cell mediated fast allergic responses in mice and rats. Results Lavender oil (1: 500,1: 100,1: 10,1: 1,1: 0) inhibited the concentration-dependent oncotic response of mast cells induced by complex 48/80, topical and intradermal administration also inhibited the rat-dependent passive cutaneous allergic response induced by anti-DNP IgE; they also inhibit their induced concentration-dependent histamine release from peritoneal mast cells. Furthermore, lavender oil (1: 100,1: 10,1: 1,1: 0) has significant inhibitory effect on the secretion of tumor necrosis factor of peritoneal mast cells. These results indicate that the fast allergic reaction inhibiting effect of lavender oil is by inhibiting the degranulation of mast cells.

5) Other effects of Lavender

Hohman (1999) experiments demonstrated that 50% methanol extract of Lavandula angustifolia can inhibit Lipid Peroxidation (LPO), wherein rosmarinic acid, a phenolic component, is an antioxidant active. The lavender flower water extract can prevent glutamic acid-induced infantile cerebellar granular cell culture neurotoxicity, but has dose-related effect of neuroprotection. It has been reported that a cosmetic liquid containing lavender flower extract has an effect of degrading fat. Further, it has been reported that lavandula angustifolia volatile oil (which has an antibody-producing activity in a hemolytic plaque assay) and an extract of flowers or whole plants are added to foods or drinks for use as an immunopotentiator.

Lavender also has diuretic, blood pressure lowering, calcium channel blocking, and mosquito and mite killing effects.

According to foreign documents, the flowers of lavender are used as a domestic medicine for treating neurogenic heartbeat, flatulence and colic and can play a diuretic role. The essential oil is an antibacterial agent and is used for smearing wounds, and has the effects of disinfecting, promoting skin healing and reducing scars. The stem, leaf and essential oil of Lavender can be used as antiseptic, and can be used for treating scald, burn, ulcer, skin rubella, eczema, psoriasis, etc., and promoting regeneration of alopecia. Many studies have demonstrated that lavender oil has the efficacy of expelling roundworms, mosquitoes and killing mites. Lavender has been reported by Spanish nationality for antipyretic, analgesic, and wound healing. Jodan people also use it for treating hemiplegia, and Uygur medicine uses lavender from India to treat vitiligo. Lavender is a traditional medicine for Xinjiang Uygur medicine, is called as Du Sai in Wu Sidi in the Uygur medicine manual of the ministry standard, has 7 traditional formulas of Lavender in the Uygur medicine manual, and is a compound medicine, and the traditional medicine is generally prepared from whole herbs. The Uygur medicine considers that the lavender is second-level damp-heat, can dissipate cold, tonify stomach and regulate brain, eliminate dampness and relieve pain, and is used for treating fullness and distention in chest and abdomen, cold cough and asthma, dizziness and headache, palpitation and shortness of breath, and joint and bone pain. The medicinal research on water extracts and alcohol extracts of lavender has been reported in foreign countries, but is less common. Nowadays, research and application of lavender are more focused on lavender essential oil. At present, over-the-counter medicine Qingfeng oil containing lavender components is sold on the market in China, and the Yunnan Baiyao aerosol also contains lavender oil;

extracting lavender essential oil by adopting distillation equipment in the prior art; in the prior art, lavender flower wax (lavender wax) is prepared by taking carbon dioxide with a fragrance flower specification as a solvent and adopting a supercritical fluid extraction technology, and the lavender flower floc dried in the shade is subjected to crushing, extraction, filtration, separation and purification preparation processes to prepare a yellow-green semisolid or solid wax-like paste substance with characteristic fragrance of lavender; lavender absolute (lavender absolute), in the prior art, carbon dioxide with a fragrance flower specification is used as a solvent, a supercritical fluid extraction technology is adopted, and lavender catkin dried in a shade is subjected to crushing, extraction, filtration, separation and purification preparation processes to prepare yellowish green oily flowing liquid with characteristic fragrance of lavender; lavender extract is prepared by extracting, filtering and concentrating lavender catkin by using edible ethanol with a fragrance flower specification as a solvent and adopting an ultrasonic technology in the prior art to prepare dark brown thick paste with characteristic fragrance of lavender.

The fragrance slow-release agent can be lavender fragrance slow-release microcapsules or lavender fragrance slow-release nanocapsules, and the lavender fragrance slow-release microcapsules are particles formed by wrapping lavender essential oil, lavender flower wax, lavender absolute oil or other fragrance substances with various micron-sized film-forming materials; the lavender fragrance slow-release nano capsule is particles formed by wrapping lavender essential oil, lavender flower wax, lavender absolute oil or other fragrance substances with various nanoscale film-forming materials.

The lavender material is one or more of lavender flower bud, lavender leaf and lavender stem.

Example two:

the invention relates to a novel lavender fragrance source, which comprises the following raw materials in parts by weight: 70 parts of lavender material, 0.1 part of lavender flower wax, 0.1 part of lavender absolute, 3 parts of valerian essential oil, 0.04 part of limonene, 0.06 part of beta-pinene, 0.04 part of gamma-terpinene, 0.01 part of linalool, 0.01 part of geraniol, 0.03 part of nerol, 0.03 part of terpineol, 0.005 part of leaf alcohol, 0.06 part of eugenol, 0.04 part of valeric acid, 0.05 part of benzoic acid, 0.007 part of salicylic acid, 0.01 part of geranyl acetate, 0.02 part of methyl salicylate, 0.1 part of lavender extract, 1 part of adhesive, 0.01 part of bactericide and 40 parts of purified water;

example three:

the invention relates to a novel lavender fragrance source, which comprises the following raw materials in parts by weight: 60 parts of lavender material, 5 parts of lavender essential oil, 5 parts of lavender flower wax, 3 parts of lavender absolute oil, 2.5 parts of fragrance slow-release agent, 7 parts of valerian essential oil, 0.05 part of limonene, 0.065 part of beta-pinene, 0.06 part of gamma-terpinene, 0.012 part of linalool, 40.0 parts of geraniol, 0.05 part of nerol, 0.05 part of terpineol, 0.0075 part of leaf alcohol, 0.08 part of eugenol, 0.06 part of valeric acid, 0.07 part of benzoic acid, 0.009 part of salicylic acid, 0.02 part of geranyl acetate, 0.03 part of methyl salicylate, 3 parts of lavender extract, 15 parts of adhesive, 0.08 part of bactericide and 80 parts of purified water;

example four:

the invention relates to a novel lavender fragrance source, which comprises the following raw materials in parts by weight: 65 parts of lavender material, 7 parts of lavender essential oil, 8 parts of lavender flower wax, 4 parts of lavender absolute oil, 3 parts of fragrance slow-release agent, 8 parts of valerian essential oil, 0.065 part of limonene, 0.067 part of beta-pinene, 0.08 part of gamma-terpinene, 0.014 part of linalool, 0.05 part of geraniol, 0.06 part of nerol, 0.06 part of terpineol, 0.0085 part of leaf alcohol, 0.07 part of eugenol, 0.05 part of valeric acid, 0.068 part of benzoic acid, 0.011 part of salicylic acid, 0.025 part of geranyl acetate, 0.04 part of methyl salicylate, 2.5 parts of lavender extract, 8 parts of adhesive, 0.1 part of bactericide and 100 parts of purified water;

example five:

the invention relates to a novel lavender fragrance source, which comprises the following raw materials in parts by weight: 50 parts of lavender material, 10 parts of lavender essential oil, 10 parts of lavender flower wax, 5 parts of lavender absolute, 5 parts of fragrance slow-release agent, 10 parts of valerian essential oil, 0.08 part of limonene, 0.07 part of beta-pinene, 0.09 part of gamma-terpinene, 0.015 part of linalool, 0.06 part of geraniol, 0.07 part of nerol, 0.08 part of terpineol, 0.01 part of leaf alcohol, 0.09 part of eugenol, 0.08 part of valeric acid, 0.08 part of benzoic acid, 0.012 part of salicylic acid, 0.03 part of geranyl acetate, 0.05 part of methyl salicylate, 5 parts of lavender extract, 25 parts of adhesive, 0.15 part of bactericide and 150 parts of purified water;

example six:

a preparation method of a novel lavender fragrance source comprises the following steps:

s1, preparing raw materials: selecting a dry lavender material, wherein the lavender material is one or more of lavender flower buds, lavender leaves and lavender stems, and preparing lavender essential oil, lavender flower wax, lavender absolute oil, a fragrance slow-release agent, valerian essential oil, limonene, beta pinene, gamma terpinene, linalool, geraniol, nerol, terpineol, leaf alcohol, eugenol, valeric acid, benzoic acid, salicylic acid, geranyl acetate, methyl salicylate, lavender extract, a binder, a bactericide and purified water according to the weight part ratio;

s2, crushing raw materials: crushing the lavender material by adopting crushing equipment;

preferably, filtering the crushed raw materials in the step S2 by using filtering equipment to obtain 30-120 meshes of crushed lavender materials;

s3, mixing and stirring materials: adding the lavender crushed material and other prepared raw materials into a mixing device, and stirring and mixing to obtain a fragrance source mixed material;

s4, forming and manufacturing: adopting a forming device to mix the fragrance source body into a fragrance source body initial product;

s5, drying: drying the primary fragrance source product by a hot air circulation oven at 20-50 ℃ to obtain a fragrance source product, and recovering evaporated water generated in the drying process by a serpentine circulation condenser; the recovered aroma can be reused.

S6, packaging and warehousing: inspecting the fragrance source product, packaging with food-grade plastic bags after the inspection is qualified, quantitatively sealing each bag, and packaging into a warehouse.

The used and abandoned fragrance sources (pills and blocks) can be recycled again and used as biological energy raw materials, and the energy-saving comprehensive utilization effect is remarkable.

And between the step S5 and the step S6, polishing the fragrance source product by adopting polishing equipment. The adhesive is syrup or corn starch, and the bactericide is dichlorobenzyl alcohol.

The pulverizing equipment adopts YSF-25 type Chinese medicinal cell wall breaking pulverizer or ZJ-BC100 type hierarchical impact mill, and the mixing equipment adopts WCH-100 type groove mixer. The forming equipment adopts a WK-300 type semi-automatic traditional Chinese medicine pill making machine or an MM08/15/30/60 type casting machine.

Example 1: a novel lavender fragrance source used for small-sized treatment carriers (such as treatment eyepatches) comprises the following raw materials in parts by weight: 70 parts of lavender material, 0.1 part of lavender flower wax, 0.1 part of lavender absolute, 3 parts of valerian essential oil, 0.04 part of limonene, 0.06 part of beta-pinene, 0.04 part of gamma-terpinene, 0.01 part of linalool, 0.01 part of geraniol, 0.03 part of nerol, 0.03 part of terpineol, 0.005 part of leaf alcohol, 0.06 part of eugenol, 0.04 part of valeric acid, 0.05 part of benzoic acid, 0.007 part of salicylic acid, 0.01 part of geranyl acetate, 0.02 part of methyl salicylate, 0.1 part of lavender extract, 1 part of adhesive, 0.01 part of bactericide and 40 parts of purified water. Wherein, the adhesive adopts syrup, and the bactericide adopts dichlorobenzyl alcohol, thereby having good sterilization and mite removal effects.

The preparation method of the novel lavender fragrance source comprises the following steps:

s1, preparing raw materials: selecting dry lavender buds, and preparing lavender flower wax, lavender absolute oil, valerian essential oil, limonene, beta pinene, gamma terpinene, linalool, geraniol, nerol, terpineol, leaf alcohol, eugenol, valeric acid, benzoic acid, salicylic acid, geranyl acetate, methyl salicylate, lavender extract, a binder, a bactericide and purified water according to the weight part ratio;

s2, crushing raw materials: pulverizing dried Lavender bud to 60-120 mesh with YSF-25 type traditional Chinese medicine cell wall breaking pulverizer at-10 deg.C for about 2 hr;

s3, mixing and stirring materials: at normal temperature, adding the crushed lavender flower bud material and other prepared raw materials into a WCH-100 type trough mixer, and stirring and mixing to obtain a fragrance source body mixed material, wherein the time is about 1 hour;

s4, forming and manufacturing: at normal temperature, a WK-300 type semi-automatic traditional Chinese medicine pill making machine is adopted to make the fragrance source body mixed material into pills, the diameter of the pills is controlled to be 3-5mm, and the pills are made into a fragrance source body primary product which takes about 2 hours;

s5, drying: drying the primary fragrance source product by a WKH-7-A hot air circulation oven at 20-50 deg.C to obtain a fragrance source product, and recovering evaporated water generated in the drying process by a serpentine circulation condenser for 3-4 hr; the water content of the fragrance source product is required to be less than or equal to 8 percent.

S6, polishing: polishing a fragrance source product (lavender fragrance pill) by adopting a WKY-600 type pill polishing machine at normal temperature for 2 hours;

s7, packaging and warehousing: and (3) inspecting the polished fragrance source product (lavender fragrance pill), packaging by adopting food-grade plastic bags after the inspection is qualified, quantitatively sealing each bag, and packaging into a warehouse.

The fragrance source product of this example can last for 12 months for middle and end notes.

Example 2: a novel lavender fragrance source used for a larger treatment carrier (such as a treatment sleeping pillow) comprises the following raw materials in parts by weight: 60 parts of lavender material, 5 parts of lavender essential oil, 5 parts of lavender flower wax, 3 parts of lavender absolute oil, 2.5 parts of fragrance slow-release agent, 7 parts of valerian essential oil, 0.05 part of limonene, 0.065 part of beta-pinene, 0.06 part of gamma-terpinene, 0.012 part of linalool, 40.0 parts of geraniol, 0.05 part of nerol, 0.05 part of terpineol, 0.0075 part of leaf alcohol, 0.08 part of eugenol, 0.06 part of valeric acid, 0.07 part of benzoic acid, 0.009 part of salicylic acid, 0.02 part of geranyl acetate, 0.03 part of methyl salicylate, 3 parts of lavender extract, 15 parts of adhesive, 0.08 part of bactericide and 80 parts of purified water. The lavender material is a mixture of lavender flower buds, lavender leaves and lavender stems, the adhesive is corn starch, the bactericide is dichlorobenzyl alcohol, and the bactericidal acarid removing effect is good.

The preparation method of the novel lavender fragrance source comprises the following steps:

s1, preparing raw materials: selecting a whole dry lavender (comprising lavender flower buds, lavender leaves and lavender stems), preparing lavender essential oil, lavender flower wax, lavender absolute oil, a fragrance slow-release agent, valerian essential oil, limonene, beta pinene, gamma terpinene, linalool, geraniol, nerol, terpineol, leaf alcohol, eugenol, valeric acid, benzoic acid, salicylic acid, geranyl acetate, methyl salicylate, lavender extract, a binder, a bactericide and purified water according to the weight part ratio;

s2, crushing raw materials: pulverizing whole lavender (including lavender flower bud, lavender leaf and lavender stalk) to 30-60 mesh with ZJ-BC100 type graded impact mill at 2-5 deg.C for about 3 hr;

s3, mixing and stirring materials: at normal temperature, adding the whole lavender crushed material and other prepared raw materials into a WCH-100 type trough mixer, and stirring and mixing to obtain a fragrance source mixed material, wherein 2 hours are needed approximately;

s4, forming and manufacturing: at normal temperature, a WK-300 type semi-automatic traditional Chinese medicine pill making machine is adopted to make the fragrance source body mixed material into pills, the diameter of the pills is controlled to be 7-9mm, and the pills are made into a fragrance source body primary product which takes about 2 hours;

s5, drying: drying the primary fragrance source product by a WKH-7-A type hot air circulation oven at 20-50 deg.C to obtain a fragrance source product, and recovering evaporated water generated in the drying process by a serpentine circulation condenser for about 15 hr; the water content of the fragrance source product is required to be less than or equal to 8 percent.

S6, packaging and warehousing: inspecting the fragrance source product, packaging with food-grade plastic bags after the inspection is qualified, quantitatively sealing each bag, and packaging into a warehouse.

The fragrance source product of the present example can last 13 months for middle and end notes.

Example 3: a novel lavender fragrance source used for a larger treatment carrier (such as a block-shaped fragrance source) comprises the following raw materials in parts by weight: 50 parts of lavender material, 10 parts of lavender essential oil, 10 parts of lavender flower wax, 5 parts of lavender absolute, 5 parts of fragrance slow-release agent, 10 parts of valerian essential oil, 0.08 part of limonene, 0.07 part of beta-pinene, 0.09 part of gamma-terpinene, 0.015 part of linalool, 0.06 part of geraniol, 0.07 part of nerol, 0.08 part of terpineol, 0.01 part of leaf alcohol, 0.09 part of eugenol, 0.08 part of valeric acid, 0.08 part of benzoic acid, 0.012 part of salicylic acid, 0.03 part of geranyl acetate, 0.05 part of methyl salicylate, 5 parts of lavender extract, 25 parts of adhesive, 0.15 part of bactericide and 150 parts of purified water. The lavender material is a mixture of lavender flower buds, lavender leaves and lavender stems, the adhesive is corn starch, the bactericide is dichlorobenzyl alcohol, and the bactericidal acarid removing effect is good.

The preparation method of the novel lavender fragrance source comprises the following steps:

s1, preparing raw materials: selecting a whole dry lavender (comprising lavender flower buds, lavender leaves and lavender stems), preparing lavender essential oil, lavender flower wax, lavender absolute oil, a fragrance slow-release agent, valerian essential oil, limonene, beta pinene, gamma terpinene, linalool, geraniol, nerol, terpineol, leaf alcohol, eugenol, valeric acid, benzoic acid, salicylic acid, geranyl acetate, methyl salicylate, lavender extract, a binder, a bactericide and purified water according to the weight part ratio;

s2, crushing raw materials: pulverizing whole Lavender (including Lavender flower bud, lavender leaf and Lavender stem) to 30-60 mesh with ZJ-BC100 type graded impact mill at 2-5 deg.C for about 2 hr;

s3, mixing and stirring materials: at normal temperature, adding the whole lavender crushed material and other prepared raw materials into a WCH-100 type trough mixer, and stirring and mixing to obtain a fragrance source mixed material, wherein the time is about 1 hour;

s4, forming and manufacturing: at normal temperature, adopting an MM08/15/30/60 type casting machine to block (fragrance source body) the fragrance source body mixed material, wherein the size of the fragrance source body is 3MM multiplied by 20MM multiplied by 30MM, and the fragrance source body mixed material is made into a fragrance source body primary product which needs about 4 hours;

s5, drying: drying the primary fragrance source product by a WKH-7-A type hot air circulation oven at 20-50 ℃ to obtain a fragrance source product, and recovering evaporated water generated in the drying process by a serpentine circulation condenser for about 10 hours; the water content of the fragrance source product is required to be less than or equal to 8 percent.

S6, packaging and warehousing: inspecting the fragrance source product, packaging with food-grade plastic bags after the fragrance source product is qualified, quantitatively sealing each bag, and packaging into a warehouse.

The fragrance source product of this example can last for 14 months for middle and end notes.

Compared with natural lavender flowers, the surface of the fragrance body prepared by the invention is more wear-resistant and not easy to ash under the action of the adhesive and the polysaccharide viscosity of lavender; the lavender extract and the adhesive are added into the fragrance body prepared by the invention, so that the pressure resistance, the wear resistance, the elasticity and the crushing resistance of the formed fragrance body can be enhanced, and the fragrance body is beneficial to being implanted into a therapeutic device carrier or being directly used as the fragrance body.

The head incense of the incense source prepared by the invention is as follows: at normal temperature, the fragrance of the fragrance source body generated at that time can be maintained for more than 30 days after the seal is opened; middle incense of the incense source body: at normal temperature, after the sealing is opened, the fragrance source still retains certain fragrance after half a year; the tail fragrance of the fragrance source body is that a certain fragrance is still kept after the fragrance source body is opened and sealed for one year at normal temperature.

The head fragrance of the traditional fragrance source, such as lavender essential oil, can be quickly volatilized within 1 hour at normal temperature, and has no middle fragrance and tail fragrance. The natural fragrance source, such as lavender flower bud, has weak head fragrance, and the natural fragrance source, such as lavender flower bud, has to be pulverized and ashed to produce middle fragrance and tail fragrance, and can generally last for 30-60 days at normal temperature.

The fragrance source of the invention can sustain the fragrance of the middle and tail fragrance for more than 12 months.

In the description herein, references to the description of "one embodiment," "an example," "a specific example," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.

The preferred embodiments of the invention disclosed above are intended to be illustrative only. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise embodiments disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best understand the invention for and utilize the invention. The invention is limited only by the claims and their full scope and equivalents.

Claims (10)

1. The novel lavender fragrance source is characterized by comprising the following raw materials in parts by weight: 50-70 parts of lavender material, 0-10 parts of lavender essential oil, 0.1-10 parts of lavender flower wax, 0.1-5 parts of lavender absolute, 0-5 parts of fragrance slow-release agent, 3-10 parts of valerian essential oil, 0.04-0.08 part of limonene, 0.06-0.07 part of beta-pinene, 0.04-0.09 part of gamma-terpinene, 0.01-0.015 part of linalool, 0.01-0.06 part of geraniol, 0.03-0.07 part of nerol, 0.03-0.08 part of terpineol, 0.005-0.01 part of leaf alcohol, 0.06-0.09 part of eugenol, 0.04-0.08 part of valeric acid, 0.05-0.08 part of benzoic acid, 0.007-0.012 part of salicylic acid, 0.01-0.03 part of geranyl acetate, 0.02-0.05 part of methyl salicylate, 0.1-5 parts of lavender oil, 0.1-5 parts of adhesive, 0.01-0.15 parts of pure water and 0.15-10 parts of bactericide.

2. The novel lavender fragrance source according to claim 1, characterized by comprising the following raw materials in parts by weight: 70 parts of lavender material, 0.1 part of lavender flower wax, 0.1 part of lavender absolute, 3 parts of valerian essential oil, 0.04 part of limonene, 0.06 part of beta-pinene, 0.04 part of gamma-terpinene, 0.01 part of linalool, 0.01 part of geraniol, 0.03 part of nerol, 0.03 part of terpineol, 0.005 part of leaf alcohol, 0.06 part of eugenol, 0.04 part of valeric acid, 0.05 part of benzoic acid, 0.007 part of salicylic acid, 0.01 part of geranyl acetate, 0.02 part of methyl salicylate, 0.1 part of lavender extract, 1 part of adhesive, 0.01 part of bactericide and 40 parts of purified water.

3. The novel lavender fragrance source according to claim 1, characterized by comprising the following raw materials in parts by weight: 60 parts of lavender material, 5 parts of lavender essential oil, 5 parts of lavender flower wax, 3 parts of lavender absolute oil, 2.5 parts of fragrance slow-release agent, 7 parts of valerian essential oil, 0.05 part of limonene, 0.065 part of beta-pinene, 0.06 part of gamma-terpinene, 0.012 part of linalool, 40.0 parts of geraniol, 0.05 part of nerol, 0.05 part of terpineol, 0.0075 part of leaf alcohol, 0.08 part of eugenol, 0.06 part of valeric acid, 0.07 part of benzoic acid, 0.009 part of salicylic acid, 0.02 part of geranyl acetate, 0.03 part of methyl salicylate, 3 parts of lavender extract, 15 parts of adhesive, 0.08 part of bactericide and 80 parts of purified water.

4. The novel lavender fragrance source according to claim 1, characterized by comprising the following raw materials in parts by weight: 65 parts of lavender material, 7 parts of lavender essential oil, 8 parts of lavender flower wax, 4 parts of lavender absolute oil, 3 parts of fragrance slow-release agent, 8 parts of valerian essential oil, 0.065 part of limonene, 0.067 part of beta-pinene, 0.08 part of gamma-terpinene, 0.014 part of linalool, 0.05 part of geraniol, 0.06 part of nerol, 0.06 part of terpineol, 0.0085 part of leaf alcohol, 0.07 part of eugenol, 0.05 part of valeric acid, 0.068 part of benzoic acid, 0.011 part of salicylic acid, 0.025 part of geranyl acetate, 0.04 part of methyl salicylate, 2.5 parts of lavender extract, 8 parts of adhesive, 0.1 part of bactericide and 100 parts of purified water.

5. The novel lavender fragrance source according to claim 1, characterized by comprising the following raw materials in parts by weight: 50 parts of lavender material, 10 parts of lavender essential oil, 10 parts of lavender flower wax, 5 parts of lavender absolute, 5 parts of fragrance slow-release agent, 10 parts of valerian essential oil, 0.08 part of limonene, 0.07 part of beta-pinene, 0.09 part of gamma-terpinene, 0.015 part of linalool, 0.06 part of geraniol, 0.07 part of nerol, 0.08 part of terpineol, 0.01 part of leaf alcohol, 0.09 part of eugenol, 0.08 part of valeric acid, 0.08 part of benzoic acid, 0.012 part of salicylic acid, 0.03 part of geranyl acetate, 0.05 part of methyl salicylate, 5 parts of lavender extract, 25 parts of adhesive, 0.15 part of bactericide and 150 parts of purified water.

6. A preparation method of a novel lavender fragrance source body, which is used for the novel lavender fragrance source body of any one of claims 1-5, and is characterized by comprising the following steps:

s1, preparing raw materials: selecting a dry lavender material, and preparing lavender essential oil, lavender flower wax, lavender absolute oil, a fragrance slow-release agent, valerian essential oil, limonene, beta pinene, gamma terpinene, linalool, geraniol, nerol, terpineol, leaf alcohol, eugenol, valeric acid, benzoic acid, salicylic acid, geranyl acetate, methyl salicylate, lavender extract, an adhesive, a bactericide and purified water according to the weight part ratio;

s2, crushing raw materials: crushing the lavender material by adopting crushing equipment;

s3, mixing and stirring materials: adding the lavender crushed material and other prepared raw materials into a mixing device, and stirring and mixing to obtain a fragrance source mixed material;

s4, forming and manufacturing: adopting a forming device to mix the fragrance source body into a fragrance source body initial product;

s5, drying: drying the primary fragrance source product by a hot air circulation oven at 20-50 ℃ to obtain a fragrance source product, and recovering evaporated water generated in the drying process by a serpentine circulation condenser;

s6, packaging and warehousing: inspecting the fragrance source product, packaging with food-grade plastic bags after the inspection is qualified, quantitatively sealing each bag, and packaging into a warehouse.

7. The preparation method of the novel lavender fragrance source according to claim 6, wherein the raw material crushed in S2 is filtered by a filtering device to obtain 30-120 mesh lavender crushed material.

8. The method for preparing a novel lavender fragrance source according to claim 6, wherein between step S5 and step S6, polishing equipment is adopted to polish the fragrance source product.

9. The method for preparing a novel lavender fragrance source according to claim 6, wherein the binder is syrup or corn starch, and the bactericide is dichlorobenzyl alcohol.

10. The method for preparing a novel lavender fragrance source according to claim 6, wherein the crushing device adopts a YSF-25 type traditional Chinese medicine cell wall breaking crusher or a ZJ-BC100 type staged impact mill;

the mixing equipment adopts a WCH-100 type groove mixer;

the forming device adopts a WK-300 type semi-automatic traditional Chinese medicine pill making machine or an MM08/15/30/60 type casting machine.